Quick Answer
United Health Products, Inc. reported Research And Development Expense of $355.9 thousand for the year ending 2024.
- United Health Products, Inc. showed a decrease of -40.6% in Research And Development Expense from 2023 to 2024.
- This data is from United Health Products, Inc.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $27.4 thousand | Q2 2019: $214.9 thousand | Q3 2019: $150.0 thousand | Q1 2020: $11.8 thousand | Q2 2020: $18.9 thousand | Q3 2020: $60.0 thousand | Q1 2021: $58.2 thousand | Q2 2021: $68.9 thousand | Q3 2021: $19.8 thousand | Q1 2022: $52.4 thousand | Q2 2022: $147.6 thousand | Q3 2022: $215.0 thousand | Q1 2023: $218.7 thousand | Q2 2023: $105.1 thousand | Q3 2023: $121.8 thousand | Q1 2024: $115.6 thousand | Q2 2024: $65.7 thousand | Q3 2024: $65.9 thousand | Q1 2025: $116.3 thousand | Q2 2025: $81.0 thousand | Q3 2025: $25.3 thousand.
- Over the full 8 years of available data (2017 to 2024), United Health Products, Inc.'s Research And Development Expense has grown by 1,685.4%.
- Historical annual values: Fiscal year 2024: $355.9 thousand | Fiscal year 2023: $598.8 thousand | Fiscal year 2022: $624.6 thousand | Fiscal year 2021: $237.5 thousand | Fiscal year 2020: $245.2 thousand | Fiscal year 2019: $666.4 thousand | Fiscal year 2018: $77.0 thousand | Fiscal year 2017: $19.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: